Localized Childhood Vulval Pemphigoid Treated with Tacrolimus Ointment

Background: Localized vulval childhood pemphigoid is a rare variant within the pemphigoid group. Although its prognosis seems favorable, the best therapeutic strategy remains unclear. Observation: We here describe the case of an 8-year-old girl presenting with a 5-year history of relapsing vulval pain and lesions suggestive of lichen sclerosus. Clinical features, light microscopy and direct immunofluorescence microscopy were consistent with vulval cicatricial pemphigoid, although the autoantigen(s) involved could not be characterized. Her disease responded to treatment with topical tacrolimus ointment 0.1% within 3 months without any evidence for disease activity, except for slight residual scarring. After 12 months, her treatment was stopped without relapse. Conclusion: This observation suggests that in this rare immune-mediated blistering disease topical tacrolimus is an interesting therapeutic option without the adverse effects associated with topical steroids.

[1]  T. Liesegang,et al.  Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. , 2003, Archives of dermatology.

[2]  M. Bradley,et al.  Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. , 2003, Archives of dermatology.

[3]  L. Borradori,et al.  Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus , 2003, The British journal of dermatology.

[4]  H. Tagami,et al.  Comparison of the Effects of Daily Applications between Topical Corticosteroid and Tacrolimus Ointments on Normal Skin: Evaluation with Noninvasive Methods , 2002, Dermatology.

[5]  J. Ortonne,et al.  Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. , 2002, Archives of dermatology.

[6]  J. Lübbe Topical Tacrolimus for Atopic Dermatitis: Euphoria and Vigilance , 2001, Dermatology.

[7]  J. Saurat,et al.  IgG Autoantibodies from a Lichen planus pemphigoides Patient Recognize the NC16A Domain of the Bullous Pemphigoid Antigen 180 , 1999, Dermatology.

[8]  T. Ruzicka,et al.  Tacrolimus: the drug for the turn of the millennium? , 1999, Archives of dermatology.

[9]  Allen,et al.  Childhood vulval pemphigoid: a clinical and immunopathological study of five patients , 1999, The British journal of dermatology.

[10]  R. Trüeb,et al.  Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens. , 1999, Journal of the American Academy of Dermatology.

[11]  C. S. Ong Tacrolimus ointment for atopic dermatitis. , 1998, The New England journal of medicine.

[12]  L Timmermann,et al.  The mechanism of action of cyclosporin A and FK506. , 1996, Clinical immunology and immunopathology.

[13]  F. Wojnarowska,et al.  Vulval cicatricial pemphigoid may mimic lichen sclerosus , 1996, The British journal of dermatology.

[14]  W. James,et al.  Childhood localized vulvar pemphigoid is a true variant of bullous pemphigoid. , 1992, Archives of dermatology.

[15]  D. V. van Thiel,et al.  Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. , 1991, Transplantation proceedings.

[16]  E. Gould,et al.  Childhood bullous pemphigoid. Clinical and immunologic features, treatment, and prognosis. , 1991, Archives of dermatology.

[17]  A. Inman,et al.  Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. , 1984, The Journal of investigative dermatology.